- Home
- DNTH vs HBNC Comparison
DNTH vs HBNC Comparison
Compare DNTH & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- HBNC
- Stock Information
- Founded
- DNTH 2015
- HBNC 1873
- Country
- DNTH United States
- HBNC United States
- Employees
- DNTH N/A
- HBNC N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- HBNC Major Banks
- Sector
- DNTH Health Care
- HBNC Finance
- Exchange
- DNTH Nasdaq
- HBNC Nasdaq
- Market Cap
- DNTH 711.2M
- HBNC 692.0M
- IPO Year
- DNTH N/A
- HBNC N/A
- Fundamental
- Price
- DNTH $21.66
- HBNC $15.95
- Analyst Decision
- DNTH Strong Buy
- HBNC Hold
- Analyst Count
- DNTH 9
- HBNC 2
- Target Price
- DNTH $46.43
- HBNC $18.50
- AVG Volume (30 Days)
- DNTH 285.9K
- HBNC 153.7K
- Earning Date
- DNTH 11-07-2024
- HBNC 01-22-2025
- Dividend Yield
- DNTH N/A
- HBNC 4.00%
- EPS Growth
- DNTH N/A
- HBNC N/A
- EPS
- DNTH N/A
- HBNC 0.48
- Revenue
- DNTH $5,366,000.00
- HBNC $183,718,000.00
- Revenue This Year
- DNTH $100.14
- HBNC N/A
- Revenue Next Year
- DNTH N/A
- HBNC $13.69
- P/E Ratio
- DNTH N/A
- HBNC $33.09
- Revenue Growth
- DNTH 51.41
- HBNC N/A
- 52 Week Low
- DNTH $14.82
- HBNC $11.18
- 52 Week High
- DNTH $33.77
- HBNC $19.18
- Technical
- Relative Strength Index (RSI)
- DNTH 45.12
- HBNC 45.56
- Support Level
- DNTH $18.72
- HBNC $15.49
- Resistance Level
- DNTH $28.65
- HBNC $16.22
- Average True Range (ATR)
- DNTH 2.31
- HBNC 0.43
- MACD
- DNTH -0.33
- HBNC 0.07
- Stochastic Oscillator
- DNTH 32.14
- HBNC 70.73
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.